EMA under fire again for poor management of conflicts of interest
This article was originally published in SRA
Executive Summary
The European Parliament today postponed discharging the European Medicines Agency's budget spending for the financial year 2009 in light of, among other things, concerns that there is no proper guarantee of the independence of experts hired to carry out scientific evaluations of human medicines at the agency1.